IP Library Granted Patent US 9,848,808
Granted Patent B2
US 9,848,808 · App. 14/335,458 · Granted Dec 26, 2017

Method for spectrophotometric blood oxygenation monitoring

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,848,808
App. No.
14/335,458
Granted
Dec 26, 2017
Kind
B2
Abstract

An apparatus and method for non-invasively determining a blood oxygen parameter value of a subject's tissue is provided. An embodiment of the method includes the steps of: a) providing a spectrophotometric sensor that includes a processing portion and a transducer, b) detecting at least a portion of transmitted light after passage through the subject's tissue and producing initial signal data from the detected light; and c) using the processing portion to: (i) determine a value representative of an attenuation of at least one wavelength of light detected; (ii) determine whether the representative attenuation value is outside a predefined range of attenuation values; and (iii) determine the blood oxygen parameter value using a first interrogation or an alternate interrogation setting.

Claims (33)

1. A method for non-invasively determining a blood oxygen parameter value of a subject's tissue, comprising:

providing a spectrophotometric sensor that includes at least one processor and at least one transducer, which transducer is operable to transmit light at a first plurality of predetermined wavelengths in a range of about 600 nm to about 900 nm into the subject's tissue at a known initial intensity value, and to sense the transmitted light;

detecting at least a portion of the transmitted light after passage through the subject's tissue using the transducer, and producing initial signal data representative of a detected intensity value of the light sensed;

using the at least one processor to execute instructions stored in a memory device, which instructions cause the processor to:

determine a value representative of an attenuation between the known initial intensity value and the detected intensity value of at least one wavelength less than about 720 nm within the first plurality of predetermined wavelengths; and

determine whether the representative attenuation value is outside a predefined range of attenuation values; and

determine the blood oxygen parameter value using a subset of the first plurality of predetermined wavelengths, which subset consists of a second plurality of wavelengths in a range of about 720 nm to about 900 nm, if the representative attenuation value is outside the predefined range of attenuation values, or using the first plurality of predetermined wavelengths if the representative attenuation value is within the predefined range of attenuation values.

2. The method of claim 1 , wherein the method is performed over a period of time, and wherein the initial signal data is produced once during the period of time.

3. The method of claim 1 , wherein the method is performed over a period of time, and wherein the initial signal data is produced more than once during the period of time.

4. The method of claim 1 , wherein the initial signal data is produced periodically during the period of time.

5. The method of claim 1 , wherein the transducer includes a light source and a plurality of light detectors.

6. The method of claim 1 , wherein the representative attenuation value is indicative of an altered tissue condition independent of the blood oxygen parameter value.

7. The method of claim 6 , wherein the altered tissue condition includes one or more of a bruise, contusion, scarring, skull fracture, concussion, surgery scarring, infection, tissue discoloration, bone discoloration, dura pigmentation, bone marrow, or forehead hair follicles.

8. A method for non-invasively determining a blood oxygen parameter value of a subject's tissue, comprising:

providing a spectrophotometric sensor that includes at least one processor and at least one transducer, which transducer is operable to transmit light at a first plurality of predetermined wavelengths in a range of about 600 nm to about 900 nm into the subject's tissue at a known initial intensity value, and to sense the transmitted light;

detecting at least a portion of the transmitted light after passage through the subject's tissue using the transducer, and producing initial signal data representative of a detected intensity value of the light sensed;

using the at least one processor to execute instructions stored in a memory device, which instructions cause the processor to:

determine a value representative of an attenuation between the known initial intensity value and the detected intensity value of at least one wavelength less than about 720 nm within the first plurality of predetermined wavelengths; and

determine a value representative of a hemoglobin concentration within the tissue;

determine whether the representative attenuation value is outside a predefined range of attenuation values associated with the determined hemoglobin concentration; and

determine the blood oxygen parameter value using a subset of the first plurality of predetermined wavelengths, which subset consists of a second plurality of wavelengths in a range of about 720 nm to about 900 nm, if the representative attenuation value is outside the predefined range of attenuation values associated with the determined hemoglobin concentration, or using the first plurality of predetermined wavelengths if the representative attenuation value is within the predefined range of attenuation values associated with the determined hemoglobin concentration.

9. The method of claim 8 , wherein the instructions causing the processor to determine a value representative of the hemoglobin concentration within the tissue include instructions that cause the processor to determine an oxyhemoglobin (HbO2) value, or a deoxyhemoglobin (Hb) value, or both.

10. A method for non-invasively determining a blood oxygen parameter value of a subject's tissue, comprising:

providing a spectrophotometric sensor that includes at least one processor and at least one transducer, which transducer is operable to transmit light at a first plurality of predetermined wavelengths in a range of about 600 nm to about 900 nm into the subject's tissue at a known initial intensity value, and to sense the transmitted light;

detecting at least a portion of the transmitted light after passage through the subject's tissue using the transducer, and producing initial signal data representative of a detected intensity value of the light sensed;

using the at least one processor to execute instructions stored in a memory device, which instructions cause the processor to:

determine a value representative of an attenuation between the known initial intensity value and the detected intensity value of at least one wavelength less than 720 nm within the first plurality of predetermined wavelengths; and

determine a value representative of the oxygen saturation value of the tissue; and

determine whether the representative attenuation value is outside a predetermined range of attenuation values associated with the determined oxygen saturation value; and

determine the blood oxygen parameter value using a subset of the first plurality of predetermined wavelengths, which subset consists of a second plurality of wavelengths in a range of about 720 nm to about 900 nm, if the representative attenuation value is outside the predefined range of attenuation values associated with the determined oxygen saturation value, or using the first plurality of predetermined wavelengths if the representative attenuation value is within the predefined range of attenuation values associated with the determined oxygen saturation value.

11. An apparatus for non-invasively determining a blood oxygen parameter value of a subject's tissue, comprising:

a spectrophotometric sensor that includes at least one processor and at least one transducer, which transducer is operable to transmit light at a first plurality of predetermined wavelengths and at a known initial intensity value into the subject's tissue, and is operable to detect at least a portion of the transmitted light after passage through the subject's tissue using the transducer, and to produce initial signal data representative of a detected intensity value of the light sensed;

wherein the at least one processor is in communication with a non-transitory memory storing instructions, which instructions when executed cause the processor to selectively determine a value representative of an attenuation between the known initial intensity value and the detected intensity value of at least one wavelength less than about 720 nm within the first plurality of predetermined wavelengths, and to determine whether the representative attenuation value is outside a predefined range of attenuation values, and to determine the blood oxygen parameter value using a subset of the first plurality of predetermined wavelengths, which subset includes a second plurality of wavelengths in a range of about 720 nm to about 900 nm, if the representative attenuation value is outside the predefined range of attenuation values, or using the first plurality of predetermined wavelengths if the representative attenuation value is within the predefined range of attenuation values.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2025
From: EDWARDS LIFESCIENCES CORPORATION; EDWARDS LIFESCIENCES LLC; EDWARDS LIFESCIENCES SÀRL; EDWARDS LIFESCIENCES HOLDING B.V.
To: BD SWITZERLAND SARL
Reel/Frame 072920/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2019
From: CAS MEDICAL SYSTEMS, INC.
To: EDWARDS LIFESCIENCES CORPORATION
Reel/Frame 050635/0654 →
RELEASE OF SECURITY INTEREST Recorded May 16, 2018
From: SOLAR CAPITAL LTD.
To: CAS MEDICAL SYSTEMS, INC.
Reel/Frame 045823/0342 →
PATENT SECURITY AGREEMENT Recorded Jun 30, 2016
From: CAS MEDICAL SYSTEMS, INC.
To: SOLAR CAPITAL LTD.
Reel/Frame 039221/0004 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 16, 2016
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS RETIRING AGENT
To: SOLAR CAPITAL LTD., AS SUCCESSOR AGENT
Reel/Frame 038711/0067 →
SECURITY INTEREST Recorded Mar 28, 2016
From: CAS MEDICAL SYSTEMS, INC.
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC (AS SUCCESSOR-IN-INTEREST TO GENERAL ELECTRIC CAPITAL CORPORATION), AS AGENT
Reel/Frame 038115/0439 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2014
From: BENNI, PAUL B.
To: CAS MEDICAL SYSTEMS, INC.
Reel/Frame 033496/0743 →